,
Article History
First Online: 18 July 2017
Competing interests
: S.T. declares no competing interests. C.S. is a consultant for Novartis and Roche, has received speaker's fees from Boehringer Ingelheim, Celgene, Eli Lilly, Epic Biosciences, GlaxoSmithKline, Grail Scientific, Novartis, Pfizer, Roche, and Servier, he is on the advisory board and has stock options of APOGEN Biotechnologies, EPIC Biosciences, and Grail Scientific, and is a founder of and has stock options from Achilles Therapeutics.